Gankyrin: A potential target for drug therapy against hepatocellular carcinoma

ISSN Print: 1937-6871
ISSN Online: 1937-688X
www.scirp.net/journal/jbise
E-mail: [email protected]

Citations

"Gankyrin: A potential target for drug therapy against hepatocellular carcinoma"
written by Shashank Gandhi, Veena Puri, Sanjeev Puri,
published by Journal of Biomedical Science and Engineering, Vol.5 No.8, 2012

has been cited by the following article(s):

[1]	In Silico Prediction and Validation of Oxygen-Regulated Protein N-myc Downstream Regulated Gene 3 and Virtual Screening of Competitive Inhibitors of L-Lactate as …
	2019

[2]	Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma
	Food and Agricultural Immunology, 2017

[1]	Gankyrin‐Protein Interactions in GI Cancers: A Novel Target of New Therapeutics Chronic Diseases and Translational Medicine, 2025 DOI:10.1002/cdt3.70025

[2]	In Silico Prediction and Validation of Oxygen-Regulated Protein N-myc Downstream Regulated Gene 3 and Virtual Screening of Competitive Inhibitors of L-Lactate as Therapeutics Letters in Drug Design & Discovery, 2019 DOI:10.2174/1570180815666180816130621

[3]	Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma Artificial Cells, Nanomedicine, and Biotechnology, 2017 DOI:10.1080/21691401.2017.1388250